Among the most relevant molecular changes included in the new classifications is the description of some new AML types with fusion genes such as DEK::NUP214, BCR::ABL1 or rearrangements involving KMT2A, MECOM and NUP98 (Table 2). This evidence concerns the gene DEK and acute myeloid leukemia.